Wnt/β-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer

The poor prognosis of ovarian cancer patients mainly results from a lack of early diagnosis approaches and a high rate of relapse. Only a very modest improvement has been made in ovarian cancer patient survival with traditional treatments. More targeted therapies precisely matching each patient are...

Full description

Bibliographic Details

Published in:	Frontiers in oncology Vol. 12; p. 852260
Main Authors:	Wang, Wenyu, Cho, Untack, Yoo, Anna, Jung, Chae-Lim, Kim, Boyun, Kim, Heeyeon, Lee, Juwon, Jo, HyunA, Han, Youngjin, Song, Myoung-Hyun, Lee, Ja-Oh, Kim, Se Ik, Lee, Maria, Ku, Ja-Lok, Lee, Cheol, Song, Yong Sang
Format:	Journal Article
Language:	English
Published:	Switzerland Frontiers Media S.A 12-05-2022
Subjects:	CWP232291 Oncology organoids ovarian cancer targeted therapy Wnt/β-catenin targeted therapy ovarian cancer Wnt/β-catenin organoids CWP232291
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!